As the global manufacturing sector transitions toward higher requirements for material fineness and operational safety, Shandong Jingxin Powder Equipment Technology Co., Ltd. has announced technical ...

As industries like pharmaceuticals, energy storage, and specialty chemicals continue to expand, the need for precise, high-performance powder processing equipment becomes even more critical. In the ...

Among emerging solutions, Advanced High-Tech Air Flow Mill Solutions are gaining attention for their ability to achieve uniform particle sizes, maintain material purity, and provide improved control ...

As a Global Leading Stable Superfine Pulverizer Manufacturer, JINGXIN stands as a pillar in the field of superfine grinding technology. With a commitment to precision, innovation, and superior quality ...

Key stocks like Tata Steel, SBI, and Varun Beverages will be in focus on Wednesday due to significant corporate developments.

ZHONGSHAN CITY, GUANGDONG PROVINCE, CHINA, March 19, 2026 /EINPresswire.com/ -- In industries where a single particle ...

Jordan Armstrong, VP of Business Development at AssistRX, explains how companies can tailor direct-to-patient strategies into their commercialization plans. At this year’s Access USA conference, ...

The Netherlands is falling behind other European countries in providing access to advanced therapy medicinal products (ATMPs) according to Peter Fassler, Director of Market Access at Gilead Sciences, ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.

Protagonist Therapeutics will now sit back and collect cash from the J&J partnership, including an immediate $50 million payment.

Cold Chain Technologies (CCT) has announced the upcoming launch of MedAssure, a new cold chain orchestration platform. The platform will be officially introduced at LogiPharma 2026, where the company ...

Ligand Pharma (LGND) outperforms via a high-margin royalty model and disciplined investing. Click here to read my most recent ...